COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis (ATOM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00579956
Recruitment Status : Unknown
Verified August 2007 by University of Oxford.
Recruitment status was:  Recruiting
First Posted : December 24, 2007
Last Update Posted : June 4, 2008
Mahidol University
Wellcome Trust
Information provided by:
University of Oxford

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 2010
Estimated Study Completion Date : September 2010
Publications automatically indexed to this study by Identifier (NCT Number):